Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Genomic Biomarker Market from 2025 to 2034, and What Factors Influence It?

The market size for genomic biomarkers has seen a swift expansion in the past few years, accelerating from a worth of $8.4 billion in 2024 to $9.9 billion in 2025, indicating a compound annual growth rate (CAGR) of 18.0%. This surge in the historic phase is due to heightened awareness of genetic disorders, escalated demand for specialized therapies, a rise in the usage of vast data in genomics, expansion in worldwide genomic databases, and an increase in biomarker-focused clinical trials.

The market size of genomic biomarkers is set to witness speedy expansion in the following years, expected to reach $18.93 billion by 2029, with a compound annual growth rate of 17.6%. The projected increase in this period can be linked to the heightened emphasis on the provision of personalized drugs, growing instances of cardiovascular ailments, an increased number of neuro-disease patients, escalated funding in genomic exploration, and the rise in personalized nutrition adoption. Noteworthy trends in the prediction period encompass technological progression, digital health, artificial intelligence, machine learning, and customized medicine.

How Are the key drivers expanding the growth of the Genomic Biomarker Market?

The rise in chronic diseases is predicted to fuel the expansion of the genomic biomarker market. Chronic diseases, which are typically enduring and tend to develop slowly over time, are increasingly prevalent due to aging populations and the growing incidence of lifestyle-related illnesses like obesity and diabetes. Genomic biomarkers facilitate the early identification of these diseases and the development of individualized preventative measures by detecting genetic predispositions and creating targeted interventions. This forward-thinking strategy assists in decreasing prevalence by reaching those at risk before the disease develops. For example, the World Health Organization, a Switzerland-based intergovernmental body, disclosed in September 2023 that every year, chronic diseases are responsible for 74% of all deaths worldwide, an alarming 41 million deaths. Included in this figure are 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the escalating prevalence of chronic diseases propels the genomic biomarker market’s expansion.

Get Your Free Sample of the Global Genomic Biomarker Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=20557&type=smp

Who Are the Leading Players Fueling Growth in the Genomic Biomarker Market?

Major companies operating in the genomic biomarker market are:

• Pfizer Inc.

• Roche Diagnostics

• Thermo Fisher Scientific Inc.

• Merck KGaA

• Eurofins Scientific SE

What Are the Emerging Trends Shaping the Future of the Genomic Biomarker Market?

Leading organizations involved in the genomic biomarker industry are concentrating on the production of innovative items such as advanced liquid biopsy assays. These assays facilitate detailed genomic profiling of solid tumors. Liquid biopsy assays examine genetic matter, usually circulating tumor DNA (ctDNA), from a blood specimen to identify and monitor cancer. Spotting genomic biomarkers allows us to gather data on specific mutations, gene expression patterns, and other genetic changes linked to cancer. For instance, in November 2023, Illumina Inc., an American biotech firm, introduced an advanced liquid biopsy assay, known as TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2), for extensive genomic profiling of solid tumors. The assay can detect variations with a lower frequency by examining only 20 ng of cell-free DNA, reduced from 30 ng. It produces results in less than four days, thereby hastening the genomic profiling process compared to traditional techniques. Its simplified procedure and impending automation will ease lab incorporation and enhance productivity.

Get Instant Access to the Global Genomic Biomarker Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/genomic-biomarker-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Genomic Biomarker Market?

The genomic biomarker market covered in this report is segmented –

1) By Type: Predictive Biomarkers, Prognostic Biomarkers

2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications

3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility

4) By End-User: Hospitals, Diagnostic Centers, Research Laboratories, Other End Users

Subsegments:

1) By Predictive Biomarkers: Genetic Biomarkers For Disease Susceptibility, Pharmacogenomic Biomarkers For Drug Response, Early Detection Biomarkers For Disease Prediction, Biomarkers For Treatment Response Prediction

2) By Prognostic Biomarkers: Biomarkers For Disease Progression, Biomarkers For Outcome Prediction, Survival And Recurrence Biomarkers, Biomarkers For Treatment Efficacy And Prognosis

Which Regions Are Driving Growth in the Genomic Biomarker Market?

North America was the largest region in the genomic biomarker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Features of the Genomic Biomarker Market?

A genomic biomarker is a specific genetic sequence or molecular characteristic found in an individual’s genome that can assess disease risk, predict disease progression, or determine response to a particular treatment. These biomarkers are often used in personalized medicine to tailor treatments based on an individual’s genetic profile.

Browse Through More Similar Reports By The Business Research Company:

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Cancer Biomarker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: